Gynecologic Oncology Group — Philadelphia, Pennsylvania

Gynecologic Oncology Group is a clinical research site located in Philadelphia, Pennsylvania, United States 19103.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Gynecologic Oncology Group has participated in 57 clinical trials with 1 currently active.

Therapeutic areas: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection.

Sponsors: National Cancer Institute (NCI), Gynecologic Oncology Group.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gynecologic Oncology Group?

Gynecologic Oncology Group has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gynecologic Oncology Group conducted?

Gynecologic Oncology Group has 57 clinical trials on record, with 1 currently active. Their work covers Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection.

Is Gynecologic Oncology Group accredited by Crixeo Health?

Yes — Gynecologic Oncology Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Gynecologic Oncology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.